Finance

Lists
JBIO:NASDAQ
Jade Biosciences Inc
$ 14.39
+1.70%
(+0.24) 1D
10-р сарын 9, 16:00:01 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JBIO...
Open
$ 14.16
High
$ 14.81
Low
$ 14.00
Mkt. cap
915.17 сая
Avg. vol.
959.89 мян
Volume
0.00
52-wk high
$ 27.96
52-wk low
$ 8.36
EPS
-$ 2.31
Beta
1.64
Shares outstanding
63.60 сая
No. of employees
55
Open
$ 14.16
High
$ 14.81
Low
$ 14.00
Mkt. cap
915.17 сая
Avg. vol.
959.89 мян
Volume
0.00
52-wk high
$ 27.96
52-wk low
$ 8.36
EPS
-$ 2.31
Beta
1.64
Shares outstanding
63.60 сая
No. of employees
55
News stories
From web sources and news partners
About Jade Biosciences Inc
CEO-
Employees55
Founded2024
HeadquartersWaltham, Массачусеттс, Америкийн Нэгдсэн Улс
Sector-
Websitejadebiosciences.com
Analyst ratings
Based on 10 analysts giving stock ratings to JBIO in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for JBIO in the last 3 months.
Highest
Current $ 14.39
$ 77.00 (+435.09%)
Average
$ 50.50 (+250.94%)
Lowest
$ 40.00 (+177.97%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vamil Divan
Guggenheim
Buy
Reiterated
$ 47.00
+226.6%
10/01/2026
David Nierengarten
Wedbush
Buy
Maintained
$ 47.00
+226.6%
10/01/2026
Arthur He CFA
H.C. Wainwright
Buy
Maintained
$ 55.00
+282.2%
10/01/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
09/30/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$ 42.00
+191.9%
09/30/2026
Kaveri Pohlman
Clear Street
Buy
Reiterated
$ 48.00
+233.6%
09/04/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
$ 40.00
+178%
08/13/2026
Akash Tewari
Jefferies
Buy
Maintained
$ 48.00
+233.6%
08/11/2026
Laura Chico
Wedbush
Buy
Maintained
$ 47.00
+226.6%
08/11/2026
Julian Harrison
BTIG
Buy
Maintained
$ 77.00
+435.1%
08/10/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
08/10/2026
Michael Yee
UBS
Buy
Initiated
$ 45.00
+212.7%
06/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
22.01 сая
28.54 сая
36.05 сая
50.06 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.39 сая
6.44 сая
7.39 сая
8.85 сая
Operating expense
27.40 сая
34.98 сая
43.44 сая
58.92 сая
Total operating expenses
27.40 сая
34.98 сая
43.44 сая
58.92 сая
Operating income
-27.40 сая
-34.98 сая
-43.44 сая
-58.92 сая
Other non operating income
-28.00 мян
20.00 мян
-9.00 мян
-62.00 мян
EBT including unusual items
-25.18 сая
-31.87 сая
-40.35 сая
-55.75 сая
EBT excluding unusual items
-25.18 сая
-31.87 сая
-40.35 сая
-55.75 сая
Income tax expense
-
58.00 мян
16.00 мян
15.00 мян
Effective tax rate
-
-0.18%
-0.04%
-0.03%
Other operating expenses
-
-
-
-
Net income
-25.18 сая
-31.93 сая
-40.37 сая
-55.76 сая
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-0.76
Interest and investment income
2.25 сая
3.08 сая
3.10 сая
3.23 сая
Interest expense
-
-
-
-
Net interest expenses
2.25 сая
3.08 сая
3.10 сая
3.23 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.39 сая
-34.97 сая
-43.44 сая
-58.91 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google аппс